Antibodies Applications and New Developments

by

Eline P. Meulenberg

DOI: 10.2174/97816080526461120101
eISBN: 978-1-60805-264-6, 2012
ISBN: 978-1-60805-586-9



Indexed in: Scopus, Book Citation Index, Science (BKCI-S), Web of Science, BIOSIS Previews, EBSCO.

Antibodies Applications and New Developments is an overview of the current developments of techniques and methods rel...[view complete introduction]
US $
Buy Personal eBook
49
Order Library eBook
196
Order Printed Copy
*155
Order PDF + Printed Copy (Special Offer)
*179

*(Excluding Mailing and Handling)

🔒Secure Checkout Personal information is secured with SSL technology
Download Flyer

Therapeutic Antibodies: State of the Art and Promises

- Pp. 280-299 (20)

Patrick Chames and Daniel Baty

Abstract

With more than 25 molecules in clinical use, monoclonal antibodies have finally come of age as therapeutics, generating a market value of $11 billion in 2004, expected to reach $26 billion by 2010. While delivering interesting results in the treatment of several major diseases including autoimmune, cardiovascular and infectious diseases, cancer and inflammation, clinical trials and research are generating a wealth of useful information, for instance about associations of clinical responses with Fc receptor polymorphisms and the infiltration and recruitment of effector cells into targeted tissues. Some functional limitations of therapeutic antibodies have come to light such as inadequate pharmacokinetics and tissue accessibility as well as impaired interactions with the immune system. This review aims at giving an overview of the current state of the art and describes the most promising avenues that are followed for generating the next generation of antibody-based cancer therapeutics, with a special emphasis on bispecific antibodies.

Purchase Chapter  Book Details

Advertisement

Novel Antibody Therapeutics Congress

Webmaster Contact: info@benthamscience.net Copyright © 2019 Bentham Science